MedPath
TGA Approval

TALZENNA talazoparib (as tosilate) 0.25 mg capsule bottle (310751)

310751

TALZENNA talazoparib (as tosilate) 0.25 mg capsule bottle

Pfizer Australia Pty Ltd

November 18, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/b7e3ff96ba62571f0798cc5c73cff4db.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/9445f060fbd3575b617afaffd04a5678.pdf

Active Ingredients

talazoparib tosilate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TALZENNA talazoparib (as tosilate) 0.25 mg capsule bottle (310751) - TGA 批准文号 | MedPath